Zacks Research Analysts Increase Earnings Estimates for ARWR

Дата публикации: 10-08-2026 05:43:06

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Stock analysts at Zacks Research lifted their FY2026 EPS estimates for shares of Arrowhead Pharmaceuticals in a research note issued to investors on Wednesday, August 5th. Zacks Research analyst D. Bautz now forecasts that the biotechnology company will post earnings of ($3.45) per share for the year, […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	HC Wainwright Issues Pessimistic Estimate for ARWR Earnings	0	13.33	10-08-2026
2	Zacks Research Lifts Earnings Estimates for Bread Financial	0	11.13	10-08-2026
3	FY2027 Earnings Forecast for Ardelyx Issued By HC Wainwright	0	13.4	10-08-2026
4	Zacks Research Issues Negative Forecast for Autoliv Earnings	0	12.28	10-08-2026
5	What is Zacks Research’s Forecast for Dover Q4 Earnings?	0	11.83	10-08-2026
6	Arrow Electronics (NYSE:ARW) Price Target Raised to $200.00	0	13.43	10-08-2026
7	Research Analysts Offer Predictions for AMPX FY2026 Earnings	0	13.82	10-08-2026
8	Northland Securities Boosts Earnings Estimates for TeraWulf	0	11.85	10-08-2026
9	Q3 EPS Estimate for SAB Biotherapeutics Boosted by Analyst	0	11.83	10-08-2026
10	Truist Financial Cuts Arrow Electronics (NYSE:ARW) Price Target to $250.00	0	10.8	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.84. Источник: www.americanbankingnews.com.